Enteroaggregative Escherichia coli - Escherichia coli: Pathotypes and Principles of Pathogenesis - page 263

Steiner, T., Flores, C., Pizarro, T., Guerrant, R., 1997. Fecal lactoferrin, interleukin-1ß, and interleu-
kin-8 are elevated in patients with severe Clostridium dificile colitis. Clin. Diag. Lab. Immunol.
4 (6), 179-722 .
Steiner, T.S., Lima, A.A., Nataro, J.P., Guerrant, R.L., 1998. Enteroaggregative Escherichia coli
produce intestinal inlammation and growth impairment and cause interleukin-8 release from
intestinal epithelial cells. J. Infect. Dis. 177 (1), 88-96 .
Steiner, T.S., Nataro, J.P., Poteet-Smith, C.E., Smith, J.A., Guerrant, R.L., 2000. Enteroaggregative
Escherichia coli expresses a novel lagellin that causes IL-8 release from intestinal epithelial
cells. J. Clin. Invest. 105 (12), 1769-1777 .
Strauman, M.C., Harper, J.M., Harrington, S.M., Boll, E.J., Nataro, J.P., 2010. Enteroaggregative
Escherichia coli disrupts epithelial cell tight junctions. Infect. Immun. 78 (11), 4958-4964 .
Sui, B.Q., Dutta, P.R., Nataro, J.P., 2003. Intracellular expression of the plasmid-encoded toxin from
enteroaggregative Escherichia coli . Infect. Immun. 71 (9), 5364-5370 .
Suzart, S., Aparecida, T., Gomes, T., Guth, B.E., 1999. Characterization of serotypes and outer
membrane protein proiles in enteroaggregative Escherichia coli strains. Microbiol. Immunol.
43 (3), 201-205 .
Tompkins, D.S., Hudson, M.J., Smith, H.R., et al., 1999. A study of infectious intestinal disease in
England: microbiological indings in cases and controls. Commun. Dis. Public Health 2 (2), 108-113 .
Tzipori, S., Montanaro, J., Robins-Browne, R.M., Vial, P., Gibson, R., Levine, M.M., 1992. Studies
with enteroaggregative Escherichia coli in the gnotobiotic piglet gastroenteritis model. Infect.
Immun. 60 (12), 5302-5306 .
Uber, A.P., Trabulsi, L.R., Irino, K., et al., 2006. Enteroaggregative Escherichia coli from humans
and animals differ in major phenotypical traits and virulence genes. FEMS Microbiol. Lett. 256
(2), 251-257 .
Valentiner-Branth, P., Steinsland, H., Fischer, T.K., et al., 2003. Cohort study of Guinean children:
incidence, pathogenicity, conferred protection, and attributable risk for enteropathogens during
the irst 2 years of life. J. Clin. Microbiol. 41 (9), 4238-4245 .
Valentiner-Branth, P., Steinsland, H., Santos, G., et al., 2001. Community-based controlled trial of
dietary management of children with persistent diarrhea: sustained beneicial effect on ponderal
and linear growth. Am. J. Clin. Nutr. 73 (5), 968-974 .
Vial, P.A., Robins-Browne, R., Lior, H., et al., 1988. Characterization of enteroadherent-aggregative
Escherichia coli , a putative agent of diarrheal disease. J. Infect. Dis. 158 (1), 70-79 .
Vila, J., Vargas, M., Henderson, I.R., Gascon, J., Nataro, J.P., 2000. Enteroaggregative Escherichia
coli virulence factors in traveler's diarrhea strains. J. Infect. Dis. 182 (6), 1780-1783 .
Villaseca, J.M., Navarro-Garcia, F., Mendoza-Hernandez, G., Nataro, J.P., Cravioto, A., Eslava, C.,
2000. Pet toxin from enteroaggregative Escherichia coli produces cellular damage associated
with fodrin disruption. Infect. Immun. 68 (10), 5920-5927 .
Wanke, C.A., 2001. To know Escherichia coli is to know bacterial diarrheal disease. Clin. Infect.
Dis. 32 (12), 1710-1712 .
Wanke, C.A., Gerrior, J., Blais, V., Mayer, H., Acheson, D., 1998a. Successful treatment of diar-
rheal disease associated with enteroaggregative Escherichia coli in adults infected with human
immunodeiciency virus. J. Infect. Dis. 178 (5), 1369-1372 .
Wanke, C.A., Mayer, H., Weber, R., Zbinden, R., Watson, D.A., Acheson, D., 1998b. Enteroaggre-
gative Escherichia coli as a potential cause of diarrheal disease in adults infected with human
immunodeiciency virus. J. Infect. Dis. 178 (1), 185-190 .
Wanke, C.A., Schorling, J.B., Barrett, L.J., Desouza, M.A., Guerrant, R.L., 1991. Potential role of
adherence traits of Escherichia coli in persistent diarrhea in an urban Brazilian slum. Pediatr.
Infect. Dis. J. 10 (10), 746-751 .